Details
Title
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Author
Rodriguez-Otero, Paula 1
; van de Donk, Niels W. C. J. 2 ; Pillarisetti, Kodandaram 3 ; Cornax, Ingrid 4 ; Vishwamitra, Deeksha 3 ; Gray, Kathleen 5 ; Hilder, Brandi 3 ; Tolbert, Jaszianne 3 ; Renaud, Thomas 6 ; Masterson, Tara 3 ; Heuck, Christoph 3 ; Kane, Colleen 3 ; Verona, Raluca 3 ; Moreau, Philippe 7
; Bahlis, Nizar 8
; Chari, Ajai 9
1 Clínica Universidad de Navarra, CCUN, University of Navarra, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271)
2 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
3 Janssen Research & Development, Spring House, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
4 Janssen Research & Development, La Jolla, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
5 Janssen Scientific Affairs, Horsham, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4978)
6 Janssen Research & Development, Raritan, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
7 University Hospital Hôtel-Dieu, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)
8 University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
9 Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
; van de Donk, Niels W. C. J. 2 ; Pillarisetti, Kodandaram 3 ; Cornax, Ingrid 4 ; Vishwamitra, Deeksha 3 ; Gray, Kathleen 5 ; Hilder, Brandi 3 ; Tolbert, Jaszianne 3 ; Renaud, Thomas 6 ; Masterson, Tara 3 ; Heuck, Christoph 3 ; Kane, Colleen 3 ; Verona, Raluca 3 ; Moreau, Philippe 7
; Bahlis, Nizar 8
; Chari, Ajai 9 1 Clínica Universidad de Navarra, CCUN, University of Navarra, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271)
2 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
3 Janssen Research & Development, Spring House, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
4 Janssen Research & Development, La Jolla, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
5 Janssen Scientific Affairs, Horsham, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4978)
6 Janssen Research & Development, Raritan, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
7 University Hospital Hôtel-Dieu, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)
8 University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
9 Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
Pages
40
Publication year
2024
Publication date
Dec 2024
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2938141391
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.